CVS Health Reaffirms 2023 Adj. EPS Guidance; Q4 Adj. Operating Profit Declines
CVS Health Corp. (CVS) issued its full-year 2023 GAAP EPS guidance range of $7.73 to $7.93 and reaffirmed its full-year adjusted EPS guidance range of $8.70 to $8.90. The company … Read More
